- Home
- FHTX vs TREE Comparison
FHTX vs TREE Comparison
Compare FHTX & TREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- TREE
- Stock Information
- Founded
- FHTX 2015
- TREE 1996
- Country
- FHTX United States
- TREE United States
- Employees
- FHTX N/A
- TREE N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- TREE Finance: Consumer Services
- Sector
- FHTX Health Care
- TREE Finance
- Exchange
- FHTX Nasdaq
- TREE Nasdaq
- Market Cap
- FHTX 513.7M
- TREE 573.8M
- IPO Year
- FHTX 2020
- TREE N/A
- Fundamental
- Price
- FHTX $5.14
- TREE $39.61
- Analyst Decision
- FHTX Strong Buy
- TREE Buy
- Analyst Count
- FHTX 5
- TREE 8
- Target Price
- FHTX $13.80
- TREE $64.00
- AVG Volume (30 Days)
- FHTX 197.3K
- TREE 387.0K
- Earning Date
- FHTX 11-04-2024
- TREE 10-31-2024
- Dividend Yield
- FHTX N/A
- TREE N/A
- EPS Growth
- FHTX N/A
- TREE N/A
- EPS
- FHTX N/A
- TREE N/A
- Revenue
- FHTX $25,515,000.00
- TREE $773,050,000.00
- Revenue This Year
- FHTX N/A
- TREE $32.88
- Revenue Next Year
- FHTX $11.54
- TREE $16.82
- P/E Ratio
- FHTX N/A
- TREE N/A
- Revenue Growth
- FHTX N/A
- TREE 4.44
- 52 Week Low
- FHTX $2.70
- TREE $24.55
- 52 Week High
- FHTX $10.25
- TREE $62.49
- Technical
- Relative Strength Index (RSI)
- FHTX 27.35
- TREE 40.31
- Support Level
- FHTX $4.69
- TREE $38.28
- Resistance Level
- FHTX $5.70
- TREE $43.45
- Average True Range (ATR)
- FHTX 0.61
- TREE 2.87
- MACD
- FHTX -0.14
- TREE 0.25
- Stochastic Oscillator
- FHTX 16.24
- TREE 50.80
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About TREE LendingTree Inc.
LendingTree Inc is a United States-based company that is principally engaged in operating an online loan marketplace. The company provides online tools and resources that can help consumers find loans or other credit-based offerings They need, including mortgage loans, reverse mortgage, home equity, personal loans, auto loans, credit cards, student loans, small business loans, and other related offerings. The company offers consumers direct access to a broad range of lenders. They have three reportable segments which are Home, Consumer, and Insurance. The company generates match fees by matching consumers with lenders, and closing fees from lenders on loans when a transaction is closed. The company operates business solely in the United States.